T Rowe is trading at 6.90 as of the 22nd of November 2024; that is 0.14 percent down since the beginning of the trading day. The fund's open price was 6.91. T Rowe has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for T Rowe Price are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Normally, the fund invests at least 80 percent of its net assets in foreign bonds. It may invest up to 25 percent of its total assets in junk bonds that have received a below investment-grade rating from each of the rating agencies that has assigned a rating to the bond or deemed by T.Rowe Price to be below investment-grade quality, including those in default or with the lowest rating. More on T Rowe Price
T Rowe Price [RPISX] is traded in USA and was established 22nd of November 2024. T Rowe is listed under T. Rowe Price category by Fama And French industry classification. The fund is listed under World Bond category and is part of T. Rowe Price family. This fund at this time has accumulated 1.79 B in assets with no minimum investment requirementsT Rowe Price is currently producing year-to-date (YTD) return of 0.11% with the current yeild of 0.0%, while the total return for the last 3 years was -6.32%.
Check T Rowe Probability Of Bankruptcy
Other Information on Investing in RPISX Mutual Fund
T Rowe financial ratios help investors to determine whether RPISX Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RPISX with respect to the benefits of owning T Rowe security.
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance